Literature DB >> 28082077

Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.

Tasuku Mashiba1, Mitsuru Saito2, Yoshiki Yamagami3, Makoto Tanaka4, Ken Iwata3, Tetsuji Yamamoto3.   

Abstract

Collagen crosslinking is an important determinant of the quality of bone material. We have previously shown that suppressed bone turnover by high doses of minodronic acid and alendronate increases compressive strength of vertebra, but also increases microdamage accumulation, in monkey bone. The aim of this study is to examine the effects of these bisphosphonates on collagen crosslinks and intrinsic material properties, in addition to microdamage accumulation, in vertebral cancellous bone in ovariectomized cynomolgus monkeys. Sixty female monkeys aged 9-17years were divided into five groups: sham and ovariectomized groups were treated daily for 17months with lactose vehicle, and the other three groups were given minodronic acid daily at 0.015 or 0.15mg/kg or alendronate daily at 0.5mg/kg orally. After sacrifice, lumbar vertebrae were subjected to histomorphometry, microdamage measurement, analysis of collagen crosslinking and compressive mechanical tests. Minodronic acid caused dose-dependent suppression of increased bone remodeling due to ovariectomy, and low-dose minodronic acid suppressed remodeling same level as alendronate. However, low-dose minodronic acid did not change microdamage accumulation, collagen maturity and the pentosidine level, whereas high-dose minodronic acid and alendronate increased these parameters. Compressive ultimate load was increased following high-dose minodronic acid and alendronate, but no treatment altered the reduction in intrinsic material properties caused by ovariectomy. These findings suggest that deterioration of bone material and formation of pentosidine and microdamage induced by minodronic acid is less than that expected based on the extent of remodeling suppression, in comparison with alendronate, but this was not reflected in any significant change of mechanical properties.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alendronate; Bone microdamage; Collagen crosslink; Mechanical property; Minodronic acid; Remodeling

Mesh:

Substances:

Year:  2017        PMID: 28082077     DOI: 10.1016/j.bone.2017.01.008

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  4 in total

1.  Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors.

Authors:  Makoto Tanaka; Akihiro Hosoya; Hiroshi Mori; Ryoji Kayasuga; Hiroaki Nakamura; Hidehiro Ozawa
Journal:  J Bone Miner Metab       Date:  2017-02-27       Impact factor: 2.626

2.  The precision study of dual energy X-ray absorptiometry for bone mineral density and body composition measurements in female cynomolgus monkeys.

Authors:  Bin Guo; Qijun Cai; Jinci Mai; Lu Hou; Chunyuan Zeng; Jiefeng Gan; Zhiqiang Tan; Yuefeng Li; Yong Cheng; Jingjie Shang; Yongjin Tang; Xueying Ling; Jian Gong; Lu Wang; Hao Xu
Journal:  Quant Imaging Med Surg       Date:  2022-03

3.  Mass spectrometric quantitation of AGEs and enzymatic crosslinks in human cancellous bone.

Authors:  Shoutaro Arakawa; Ryusuke Suzuki; Daisaburo Kurosaka; Ryo Ikeda; Hiroteru Hayashi; Tomohiro Kayama; Rei-Ichi Ohno; Ryoji Nagai; Keishi Marumo; Mitsuru Saito
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

4.  Ibandronate Suppresses Changes in Apatite Orientation and Young's Modulus Caused by Estrogen Deficiency in Rat Vertebrae.

Authors:  Takuya Ishimoto; Mitsuru Saito; Ryosuke Ozasa; Yoshihiro Matsumoto; Takayoshi Nakano
Journal:  Calcif Tissue Int       Date:  2022-01-06       Impact factor: 4.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.